Intuitive Surgical, Inc. $ISRG Shares Acquired by Atticus Wealth Management LLC

Atticus Wealth Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.2% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,030 shares of the medical equipment provider’s stock after buying an additional 505 shares during the period. Atticus Wealth Management LLC’s holdings in Intuitive Surgical were worth $560,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Norway Savings Bank lifted its position in Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares during the last quarter. Castleark Management LLC lifted its position in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Neville Rodie & Shaw Inc. lifted its position in Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the last quarter. Trust Co. of Oklahoma bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $363,000. Finally, Arlington Trust Co LLC lifted its position in Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on ISRG. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Finally, Piper Sandler restated an “overweight” rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $433.66 on Thursday. The firm’s 50 day simple moving average is $479.91 and its 200-day simple moving average is $505.85. The company has a market cap of $155.46 billion, a P/E ratio of 60.48, a price-to-earnings-growth ratio of 4.56 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.